According to a new market research study of ‘South and Central America Liposome drug delivery Market to 2027 – Regional Analysis and Forecast by Product Type, application and technology,’ the South and Central America Liposome drug delivery  market is expected to reach US$ 206.29 million by 2027 from US$ 116.72 million in 2019. The market is estimated to grow with a CAGR of 7.5% from 2020 to 2027. The report provides trends prevailing in the South and Central America Liposome drug delivery market and the factors driving market along with those that act as hindrances.

Based on the product type, the South and Central America Liposome drug delivery market is segmented into Liposomal doxorubicin, Liposomal paclitaxel, amphotericin B and others. On the basis of technology the North American Liposomal drug delivery market is segmented into Stealth liposome technology, Depofoam  liposome technology, Lysolipid thermally sensitive technology and others. And on the basis of an application it is categorized into indication in fungal diseases, cancer therapy, pain management, viral vaccines. And this market has witnessed a positive growth rate in recent periods.

Increasing Prevalence of chronic diseases, increasing demand for non-invasive drug delivery system along with rising R&D expenditures by pharmaceutical companies are some of the driving force of the market. Whereas, high cost associated with development of Non-invasive drug delivery system is about to hinder the market growth during forecast period.

Novartis AG, Luye pharma group, Ipsen  pharma, Takeda Pharmaceuticals are among the leading companies operating in the South and Central America Liposome drug delivery  market.

The report segments South and Central America Liposome Drug Delivery Market as Follows:

South and Central America Liposome drug delivery Market – By Product Type

• Liposomal Doxorubicin
• Liposomal amphotericin B
• Liposomal Paclitaxel
• Others

South and Central America Liposome drug delivery Market – By Technology

• Stealth liposome technology
• Non-PEGylated liposome technology
• DepoFoam Liposome Technology
• Lysolipid Thermally Sensitive Liposome Technology

South and Central America Liposome drug delivery Market– By Application

• South and Central America
  • Fungal diseases
  • Cancer therapy
  • Viral Vaccine
  • Pain Management